Profit Or Loss [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183196

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
22,668,000 EUR
9 030 EUR
Other income
4 809 EUR
6 574 EUR
Profit (loss) from operating activities
87 875 EUR
83 678 EUR
Finance income
2 838 EUR
1 782 EUR
Finance costs
13 116 EUR
5 987 EUR
Profit (loss) before tax
123 769 EUR
110 922 EUR
Tax expense (income)
6 895 EUR
18,835,000 EUR
Profit (loss)
116 875 EUR
116 875 EUR
92 086 EUR
92 086 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
269.00
225.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
269.00
225.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.